Anti-phospholipid Ab; APA IgM anti-phospholipid serine
Anti-phospholipid Ab; APA IgM anti-phospholipid serine
Anti-phospholipid Ab; APA IgM anti-phospholipid serine1. Anti-phospholipid Ab; APA IgM anti-phospholipid serine IgM antibody: 1600NTD, report 7-10 days
APA is a tool to assist physicians in diagnosing antiphospholipid symdrome (APS), and is used to assess the risk of thrombosis in patients with systemic lupus erythematosus (SLE). This antibody is related to the thrombosis tendency, leading to veins or arteries Thrombosis (including stroke), thrombocytopenia, reticular squash, habitual abortion
2. Anti-phosphatidylserine IgG: 1600NTD, report 7 days
It is related to reports of embolism, tumor, autoimmunity, and fetal death of pregnant women with SLE.
3. Anti-Cardiolipin IgG, IgM Anti-Cardiolipin-IgG, IgM antibody: 1600NTD, report 7 days
Anti-phospholipid syndrome, this group of patients often have any symptoms such as repeated miscarriage, arterial or venous thrombosis, and thrombocytopenia, and the presence of anti-phospholipid antibodies in the blood is named after. Antiphospholipid syndrome, without any primary disease, is called "primary antiphospholipid syndrome"; and those complicated by other diseases are called "secondary antiphospholipid syndrome". This type of concurrent disease is collagen vascular disease Most of them, especially systemic lupus erythematosus. Others such as cancer and chronic viral infections can also produce antiphospholipid syndrome.
The most common symptoms of antiphospholipid syndrome in Taiwan are repeated miscarriage, cerebral stroke, leg vein thrombosis, pulmonary hypertension, pulmonary infarction, central retinal artery or venous thrombosis, blindness, recurrent mononeuritis, and transverse spinal cord. Inflammation, renal vein or arterial embolism, sudden deafness, chorea, multi-infarct dementia, sudden change of antiphospholipid syndrome, etc. If antiphospholipid syndrome is not detected early, treated promptly and appropriately, and prevented recurrence of thrombosis, the prognosis is poor. Antiphospholipid antibodies can bind to platelets and cause blood clotting, and may also bind to the endothelial cells of blood vessels, and inhibit the release of chemicals that dilate blood vessels, thereby constricting blood vessels and causing blood clotting. The phenomenon of blood coagulation can occur in arteries or veins in any part of the body. The fluctuations in the concentration of antiphospholipid antibodies are related to the severity of the disease, and can also appear when the disease is remission. In some patients with lupus, antiphospholipid antibodies only appear during pregnancy and have to be prevented. Antiphospholipid antibodies do not necessarily cause problems when lupus erythematosus occurs. Sometimes when the disease is relieved, it can cause disease. About 1/3 of lupus patients have antiphospholipid antibodies, and 1/3 of them may develop blood clotting symptoms.